| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |